Xentria, Inc. logo

Xentria, Inc.

12 Marks
Corp.
First Filed:Apr 29, 2020Latest Filed:Feb 28, 2025Address:8700 W Bryn Mawr Ave, Chicago, IL 60631

Portfolio Overview

Registered
3(25%)
Pending
8(67%)
Dead
1(8%)

Top Classes

Class 42
Software, IT Services & Scientific Research
10(83%)
Class 36
Insurance, Financial Services & Real Estate
6(50%)
Class 35
Advertising, Business Services & Retail
6(50%)

TTAB Proceedings

Total Proceedings
1
As Plaintiff
0(0%)
As Defendant
1(100%)

Top Firms

McDonnell Boehnen Hulbert & ...(Feb 2025)
12

Trademark Portfolio

12 results

(current & previous marks)

Refine by Mark/Description🔽
Filed
Registered
Last Activity
XENTRIA
XENTRIA
Service Mark
Combined
REGISTERED
Owner:
Serial:99061795
Filed:Feb 28, 2025
Classes:42, 44
Registration:8028717
Registered:Nov 18, 2025
Goods & Services
Providing medical information; Providing health information; Research and development in the field of biologics, biosimilars, and pharmaceuticals; Providing information about medical research in the field of biologics, biosimilars, and pharmaceuticals
XENTRIA
XENTRIA
Service Mark
Combined
PENDING
Owner:
Serial:99061838
Filed:Feb 28, 2025
Classes:42, 44
Goods & Services
Providing medical information; Providing health information; Research and development in the field of biologics, biosimilars, and pharmaceuticals; Providing information about medical research in the field of biologics, biosimilars, and pharmaceuticals
XENTRIA
XENTRIA
Service Mark
Combined
REGISTERED
Owner:
Serial:99061771
Filed:Feb 28, 2025
Classes:42, 44
Registration:7960762
Registered:Sep 23, 2025
Goods & Services
Providing medical information; Providing health information; Research and development in the field of biologics, biosimilars, and pharmaceuticals; Providing information about medical research in the field of biologics, biosimilars, and pharmaceuticals
X
X
Service Mark
Stylized
PENDING
Owner:
Serial:99007677
Filed:Jan 17, 2025
Classes:35, 36, 42
Goods & Services
Providing venture capital, development capital, private equity and investment funding; Venture capital services, namely, providing financing to emerging and start-up companies; Providing venture capital, development capital, private equity and investment funding for the development of biologics, biosimilars, pharmaceuticals, and therapeutics; Venture capital services, namely, providing financing to emerging and start-up companies for the development of biologics, biosimilars, pharmaceuticals, and therapeutics; Business consulting services; Business consulting services related to biologics, biosimilars, pharmaceuticals, and therapeutics; Market analysis and research services; Business advice and analysis of markets; Market analysis and research services related to biologics, biosimilars, pharmaceuticals, and therapeutics; Business advice and analysis of markets related to biologics, biosimilars, pharmaceuticals, and therapeutics; Research and development of biologics, biosimilars, pharmaceuticals, and therapeutics; Providing information in the field of scientific and medical research related to biologics, biosimilars, pharmaceuticals, and therapeutics
X
X
Service Mark
Stylized
PENDING
Owner:
Serial:99007707
Filed:Jan 17, 2025
Classes:35, 36, 42
Goods & Services
Providing venture capital, development capital, private equity and investment funding; Venture capital services, namely, providing financing to emerging and start-up companies; Providing venture capital, development capital, private equity and investment funding for the development of biologics, biosimilars, pharmaceuticals, and therapeutics; Venture capital services, namely, providing financing to emerging and start-up companies for the development of biologics, biosimilars, pharmaceuticals, and therapeutics; Business consulting services; Business consulting services related to biologics, biosimilars, pharmaceuticals, and therapeutics; Market analysis and research services; Business advice and analysis of markets; Market analysis and research services related to biologics, biosimilars, pharmaceuticals, and therapeutics; Business advice and analysis of markets related to biologics, biosimilars, pharmaceuticals, and therapeutics; Research and development of biologics, biosimilars, pharmaceuticals, and therapeutics; Providing information in the field of scientific and medical research related to biologics, biosimilars, pharmaceuticals, and therapeutics
XENTRIA
XENTRIA
Trademark
Word
PENDING
Owner:
Serial:99007883
Filed:Jan 17, 2025
Classes:5
Goods & Services
house mark for a full line of biologic, biosimilar, and pharmaceutical preparations; house mark for a full line of biologics; house mark for a full line of biosimilars; house mark for a full line of pharmaceuticals; house mark for a full line of biologic, biosimilar, and pharmaceutical products; biologic, biosimilar, and pharmaceutical preparations for the treatment of bone disease; biologic, biosimilar, and pharmaceutical preparations for use in the treatment of oncological and metabolic diseases and disorders, and complications associated therewith; biologic, biosimilar, and pharmaceutical preparations for the treatment of diabetes; biologic, biosimilar, and pharmaceutical preparations for treatment and prevention of autoimmune diseases and autoimmune disorders; biologic, biosimilar, and pharmaceutical oncology preparations; anti-inflammatories; biologic, biosimilar, and pharmaceutical preparations for the treatment of immune system related diseases and disorders; biologic, biosimilar, and pharmaceutical preparations for use in dermatology; biologic, biosimilar, and pharmaceutical preparations for use in rheumatology; biologic, biosimilar, and pharmaceutical preparations, namely, anti-tumor necrosis factor alpha (TNFa) receptor monoclonal antibody for the treatment of disease influenced by TNFa production; biologic, biosimilar, and pharmaceutical preparations, namely, biopharmaceuticals based on human monoclonal antibodies for the treatment of immune and inflammatory diseases and disorders
XTURNPOINT
XTURNPOINT
Service Mark
Stylized
PENDING
Owner:
Serial:99007760
Filed:Jan 17, 2025
Classes:35, 36, 42
Goods & Services
Providing venture capital, development capital, private equity and investment funding; Venture capital services, namely, providing financing to emerging and start-up companies; Providing venture capital, development capital, private equity and investment funding for the development of biologics, biosimilars, pharmaceuticals, and therapeutics; Venture capital services, namely, providing financing to emerging and start-up companies for the development of biologics, biosimilars, pharmaceuticals, and therapeutics; Business consulting services; Business consulting services related to biologics, biosimilars, pharmaceuticals, and therapeutics; Market analysis and research services; Business advice and analysis of markets; Market analysis and research services related to biologics, biosimilars, pharmaceuticals, and therapeutics; Business advice and analysis of markets related to biologics, biosimilars, pharmaceuticals, and therapeutics; Research and development of biologics, biosimilars, pharmaceuticals, and therapeutics; Providing information in the field of scientific and medical research related to biologics, biosimilars, pharmaceuticals, and therapeutics
XTURNPOINT
XTURNPOINT
Service Mark
Stylized
PENDING
Owner:
Serial:99007567
Filed:Jan 17, 2025
Classes:35, 36, 42
Goods & Services
Providing venture capital, development capital, private equity and investment funding; Venture capital services, namely, providing financing to emerging and start-up companies; Providing venture capital, development capital, private equity and investment funding for the development of biologics, biosimilars, pharmaceuticals, and therapeutics; Venture capital services, namely, providing financing to emerging and start-up companies for the development of biologics, biosimilars, pharmaceuticals, and therapeutics; Business consulting services; Business consulting services related to biologics, biosimilars, pharmaceuticals, and therapeutics; Market analysis and research services; Business advice and analysis of markets; Market analysis and research services related to biologics, biosimilars, pharmaceuticals, and therapeutics; Business advice and analysis of markets related to biologics, biosimilars, pharmaceuticals, and therapeutics; Research and development of biologics, biosimilars, pharmaceuticals, and therapeutics; Providing information in the field of scientific and medical research related to biologics, biosimilars, pharmaceuticals, and therapeutics
XTURNPOINT
XTURNPOINT
Service Mark
Stylized
PENDING
Owner:
Serial:99007634
Filed:Jan 17, 2025
Classes:35, 36, 42
Goods & Services
Providing venture capital, development capital, private equity and investment funding; Venture capital services, namely, providing financing to emerging and start-up companies; Providing venture capital, development capital, private equity and investment funding for the development of biologics, biosimilars, pharmaceuticals, and therapeutics; Venture capital services, namely, providing financing to emerging and start-up companies for the development of biologics, biosimilars, pharmaceuticals, and therapeutics; Business consulting services; Business consulting services related to biologics, biosimilars, pharmaceuticals, and therapeutics; Market analysis and research services; Business advice and analysis of markets; Market analysis and research services related to biologics, biosimilars, pharmaceuticals, and therapeutics; Business advice and analysis of markets related to biologics, biosimilars, pharmaceuticals, and therapeutics; Research and development of biologics, biosimilars, pharmaceuticals, and therapeutics; Providing information in the field of scientific and medical research related to biologics, biosimilars, pharmaceuticals, and therapeutics
XTURNPOINT
XTURNPOINT
Service Mark
Stylized
PENDING
Owner:
Serial:99007812
Filed:Jan 17, 2025
Classes:35, 36, 42
Goods & Services
Providing venture capital, development capital, private equity and investment funding; Venture capital services, namely, providing financing to emerging and start-up companies; Providing venture capital, development capital, private equity and investment funding for the development of biologics, biosimilars, pharmaceuticals, and therapeutics; Venture capital services, namely, providing financing to emerging and start-up companies for the development of biologics, biosimilars, pharmaceuticals, and therapeutics; Business consulting services; Business consulting services related to biologics, biosimilars, pharmaceuticals, and therapeutics; Market analysis and research services; Business advice and analysis of markets; Market analysis and research services related to biologics, biosimilars, pharmaceuticals, and therapeutics; Business advice and analysis of markets related to biologics, biosimilars, pharmaceuticals, and therapeutics; Research and development of biologics, biosimilars, pharmaceuticals, and therapeutics; Providing information in the field of scientific and medical research related to biologics, biosimilars, pharmaceuticals, and therapeutics
TRINSERRA
TRINSERRA
Trademark
Word
ABANDONED
Owner:
Serial:88893369
Filed:Apr 29, 2020
Classes:5
XENTRIA
XENTRIA
Trademark
Word
REGISTERED
Owner:
Serial:88893382
Filed:Apr 29, 2020
Classes:5, 42, 44
Registration:7746734
Registered:Apr 1, 2025
Goods & Services
providing medical information; providing health information; research and development of biologics, biosimilars, and pharmaceuticals; providing information in the field of scientific and medical research related to biologics, biosimilars, and pharmaceuticals

Cookie Preferences

We use cookies (including Google Analytics) to improve our site and understand how visitors use it.

View our privacy policy